Andreas Vogel is a seasoned professional in regulatory affairs with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as the Senior Director and Global Regulatory Lead at Ipsen since June 2024, Andreas is responsible for a late-stage and marketed orphan medicine. Prior to this role, Andreas held the position of Senior Director and Head of International Regulatory Affairs at Apellis Pharmaceuticals, where leadership focused on regulatory approval for therapies targeting complement system-related diseases. Leadership experience also includes a tenure as Senior Director of Regulatory Science at bluebird bio, emphasizing the approval of cell-based gene therapies, and serving as Regulatory Affairs Director and Manager at Laboratoires CTRS and Laboratoires Majorelle, respectively. Educational qualifications include a Ph.D. in Developmental Biology from the University of Basel and a Master of Science from Bielefeld University.
This person is not in any teams
This person is not in any offices